Andrew N Schiff is a director of Monte Rosa Therapeutics Inc.
Person profile
Roles
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Elevation Oncology, Inc.
21 Jun 23
4
Monte Rosa Therapeutics, Inc.
15 Jun 23
4
Aclaris Therapeutics, Inc.
5 Jun 23
4
Aclaris Therapeutics, Inc.
14 Nov 22
4
Aclaris Therapeutics, Inc.
26 Oct 22
4
Aclaris Therapeutics, Inc.
19 Oct 22
4
Aclaris Therapeutics, Inc.
11 Oct 22
4
Aclaris Therapeutics, Inc.
6 Oct 22
4
Elevation Oncology, Inc.
22 Jun 22
4
Aclaris Therapeutics, Inc.
21 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jun 23 | ELEV Elevation Oncology | Stock Option Common Stock | Grant | Acquire A | Yes | No | 1.47 | 31,238 | 45.92 k | 31,238 |
14 Jun 23 | GLUE Monte Rosa Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 6.59 | 20,500 | 135.10 k | 20,500 |
2 Jun 23 | ACRS Aclaris Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 4,507 | 0.00 | 4,507 |
2 Jun 23 | ACRS Aclaris Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 4,507 | 0.00 | 0 |
1 Jun 23 | ACRS Aclaris Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 4,660 | 0.00 | 4,660 |
1 Jun 23 | ACRS Aclaris Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 8.7 | 15,750 | 137.03 k | 15,750 |
14 Nov 22 | ACRS Aclaris Therapeutics | Common Stock | Sell | Dispose S | Yes | Yes | 17.08 | 1,371 | 23.42 k | 434,455 |
11 Nov 22 | ACRS Aclaris Therapeutics | Common Stock | Sell | Dispose S | Yes | Yes | 17.0597 | 41,160 | 702.18 k | 435,826 |
10 Nov 22 | ACRS Aclaris Therapeutics | Common Stock | Sell | Dispose S | Yes | Yes | 17.0246 | 11,395 | 194.00 k | 476,986 |